Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomiopathy

被引：3
作者：
Maron, Barry J. [1 ]
机构：
[1] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2006年 / 59卷 / 06期
关键词：
D O I：
10.1016/S1885-5857(07)60001-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：527 / 530
页数：4
相关论文
共 28 条
[1]   Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy [J].
Begley, DA ;
Mohiddin, SA ;
Tripodi, D ;
Winkler, JB ;
Fananapazir, L .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (09) :1887-1896
[2]   Prevention of sudden death in hypertrophic cardiomyopathy - But which defibrillator for which patient? [J].
Boriani, G ;
Maron, BJ ;
Shen, WK ;
Spirito, P .
CIRCULATION, 2004, 110 (15) :E438-E442
[3]  
Brugada P, 2005, BRUGADA SYNDROME: FROM BENCH TO BEDSIDE, P194, DOI 10.1002/9780470994900.ch17
[4]   The utilization of the implantable defibrillator - a European enigma [J].
Camm, AJ ;
Nisam, S .
EUROPEAN HEART JOURNAL, 2000, 21 (24) :1998-2004
[5]   Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population [J].
Cecchi, F ;
Olivotto, I ;
Montereggi, A ;
Squillatini, G ;
Dolara, A ;
Maron, BJ .
HEART, 1998, 79 (04) :331-336
[6]   Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with Arrhythmogenic right ventricular cardiomyopathy/dysplasia [J].
Corrado, D ;
Leoni, L ;
Link, MS ;
Della Bella, P ;
Gaita, F ;
Curnis, A ;
Salerno, JU ;
Igidbashian, D ;
Raviele, A ;
Disertori, M ;
Zanotto, G ;
Verlato, R ;
Vergara, G ;
Delise, P ;
Turrini, P ;
Basso, C ;
Naccarella, F ;
Maddalena, F ;
Estes, NAM ;
Buja, G ;
Thiene, G .
CIRCULATION, 2003, 108 (25) :3084-3091
[7]   Hypertrophic cardiomyopathy [J].
Elliott, P ;
McKenna, WJ .
LANCET, 2004, 363 (9424) :1881-1891
[8]  
Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09
[9]   The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) [J].
Hodgkinson, KA ;
Parfrey, PS ;
Bassett, AS ;
Kupprion, C ;
Drenckhahn, J ;
Norman, MW ;
Thierfelder, L ;
Stuckless, SN ;
Dicks, EL ;
McKenna, WJ ;
Connors, SP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :400-408
[10]   Long-term follow-up of implantable cardioverter, defibrillator therapy for hypertrophic cardiomyopathy [J].
Jayatilleke, I ;
Doolan, A ;
Ingles, J ;
McGuire, M ;
Booth, V ;
Richmond, DR ;
Semsarian, C .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (09) :1192-1194
123